Analysis of association between bleomycin hydrolase and apolipoprotein e polymorphism in Alzheimer's disease

Neurological Sciences

Volumn 31, Issue 6, 2010, Pages 687-691

  Smach, Mohamed Ali ^a   Charfeddine, Bassem ^a   Lammouchi, Turkia ^b   Othman, Leila Ben ^a   Letaief, Afef ^a   Nafati, Souhir ^a   Dridi, Hedi ^a   Bennamou, Soufien ^b   Limem, Khalifa ^a  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Alzheimer's disease; Apolipoprotein E; Bleomycin hydrolase; Polymorphism; Tunisian population

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; APOLIPOPROTEIN E4; BLEOMYCIN HYDROLASE; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; ONSET AGE; SEX DIFFERENCE; TUNISIA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CYSTEINE ENDOPEPTIDASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; MALE; POLYMORPHISM, GENETIC; TUNISIA;

EID: 78650513725     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-010-0234-4     Document Type: Article

References (27)

1. J Hardy 2006 A hundred years of Alzheimer's disease research Neuron 52 3 13 10.1016/j.neuron.2006.09.016 17015223 1:CAS:528:DC%2BD28XhtFensbbE (Pubitemid 44472602)
2. WJ Strittmattet AD Roses 1995 Apolipoprotein E and Alzheimer disease Proc Natl Acad Sci USA 92 47 25 27
3. SE Montoya RE Ferrell JS Lazo 1997 Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase Cancer Res 57 4191 4195 9331073 1:CAS:528:DyaK2sXmsFChtbk%3D
4. A Papassotiropoulos M Bagli F Jessen C Frahnert ML Rao W Maier R Heun 2000 Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease Mol Psychiatry 5 213 215 10.1038/sj.mp.4000656 10822352 1:CAS:528:DC%2BD3cXlslart7k%3D
5. P Malherbe RL Faull JG Richards 2000 Regional and cellular distribution of bleomycin hydrolase mRNA in human brain: comparison between Alzheimer's disease and control brains Neurosci Lett 3 281 1 37 40 10.1016/S0304-3940(00) 00802-8 1:CAS:528:DC%2BD3cXht1OisLc%3D (Pubitemid 30109299)
6. SE Montoya CE Aston ST DeKosky MI Kamboh JS Lazo RE Ferrell 1998 Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease Nat Genet 18 211 212 10.1038/ng0398-211 9500538 1:CAS:528:DyaK1cXhtlKks74%3D
7. D Brömme AB Rossi SP Smeekens DC Anderson DG Payan 1996 Human bleomycin hydrolase: molecular cloning, sequencing, functional expression and enzymatic characterization Biochemistry 35 6706 6714 10.1021/bi960092y 8639621 (Pubitemid 26172429)
8. PA O'Farrell F Gonzalez W Zheng SA Johnston L Joshua-Tor 1999 Crystal structure of human bleomycin hydrolase, a self-compartmentalizing cysteine protease Structure 7 6 619 627 10.1016/S0969-2126(99)80083-5 10404591 (Pubitemid 29277415)
9. MI Lefterov RP Koldamova JS Lazo 2000 Human bleomycin hydrolase regulates the secretion of amyloid precursor protein FASEB J 14 1837 1847 10.1096/fj.99-0938com 10973933 1:CAS:528:DC%2BD3cXms1Clsb0%3D
10. T Chang CR Abraham 1996 A novel brain cysteine protease forms an SDS stable complex with the beta-amyloid precursor protein Ann NY Acad Sci 777 183 188 10.1111/j.1749-6632.1996.tb34417.x 8624082 1:CAS:528:DyaK28XjtVClurw%3D
11. AK Raina A Takeda A Nunomura G Perry MA Smith 1999 Genetic evidence for oxidative stress in Alzheimer's disease Neuroreport 10 6 1355 1357 10.1097/00001756-199904260-00036 10363952 1:CAS:528:DyaK1MXjvVOnu7Y%3D
12. Y Namba Y Ouchi H Hattori T Asada A Ueki K Ikeda 1999 Lack of association between bleomycin hydrolase gene polymorphism and Alzheimer's disease in Japanese people Ann Neurol 46 136 137 10.1002/1531-8249(199907)46:1<136::AID- ANA25>3.0.CO;2-M 10401796 1:STN:280:DyaK1MzivVahsQ%3D%3D (Pubitemid 29314398)
13. CJ Hu SM Sung HC Liu, et al. 2001 Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan J Neurol Sci 18 127 131
14. V Nivet Antoine MP Coulhon C Le Denmat B Hamon X Dulcire M Lefebvre F Piette P Davous D Durand D Duchassaing 2003 Maladies neurodégé nératives et polymorphisme des gènes de l'apolipoprotéine E et de la bléomycine Hydrolase Ann Biol Clin 61 61 67 1:CAS:528:DC%2BD3sXhslOmsrg%3D
15. LA Farrer CR Abraham JL Haines EA Rogaeva Y Song WT McGraw N Brindle S Premkumar WK Scott LH Yamaoka, et al. 1998 Association between bleomycin hydrolase and Alzheimer's disease in Caucasians Ann Neurol 44 5 808 811 10.1002/ana.410440515 9818937 1:CAS:528:DyaK1cXnsFChsbc%3D
16. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer 's Disease Neurology 34 7 939 944 6610841 1:STN:280: DyaL2c3ks1altQ%3D%3D
17. PR Wenham WH Price G Blandell 1991 Apolipoprotein E genotyping by one-stage PCR Lancet 337 1158 1159 10.1016/0140-6736(91)92823-K 1674030 1:STN:280:DyaK3M3is1amtg%3D%3D
18. Y Namba Y Ouchi A Takeda A Ueki K Ikeda 1999 Bleomycin hydrolase immunoreactivity in senile plaque in the brain of patients with Alzheimer's disease Brain Res 830 200 202 10.1016/S0006-8993(99)01435-3 10350576 1:CAS:528:DyaK1MXivFeht7s%3D (Pubitemid 29251729)
19. J Poirier 2005 Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease Neurobiol Aging 26 355 361 10.1016/j. neurobiolaging.2004.09.003 15639314 1:CAS:528:DC%2BD2MXitVejtQ%3D%3D (Pubitemid 40082719)
20. J Thome JC Gewirtz N Sakai V Zachariou P Retz-Junginger W Retz RS Duman M Rösler 1999 Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia? Neurosci Lett 274 37 40 10.1016/S0304-3940(99)00662-X 10530514 1:CAS:528:DyaK1MXmt1emu7c%3D (Pubitemid 29458973)
21. Llorca J, Rodríguez-Rodríguez E, Dierssen-Sotos T, Delgado-Rodríguez M, Berciano J, Combarros O (2008) Meta-analysis of genetic variability in the beta-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease. Acta Neurol Scand: 1171-14
22. JA Prince L Feuk SL Sawyer JG Ottfries A Ricksten K Nägga N Bogdanovic K Blennow AJ Brookes 2001 Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease Eur J Hum Genet 9 437 444 10.1038/sj.ejhg. 5200651 11436125 1:CAS:528:DC%2BD3MXlt12nsLk%3D (Pubitemid 32577180)
23. A Elbaz C Dufouil A Alpérovitch 2007 Interaction between genes and environment in neurodegenerative diseases C R Biol 330 318 328 10.1016/j.crvi.2007.02.018 17502288 1:CAS:528:DC%2BD2sXlt1akur0%3D (Pubitemid 46712172)
24. MA Smach B Charfeddine T Lammouchi I Harrabi L Ben Othman H Dridi S Bennamou K Limem 2008 CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele Neurosci Lett 440 2 145 149 10.1016/j.neulet.2008.05.076 18555606 1:CAS:528:DC%2BD1cXnsFClsbg%3D
25. N Lahlahi Kacem Y Bamou A Guedira M Hassani G Visvikis G Siest N Alami O Kabbaj M Lahrichi 2002 Apolipoprotein E polymorphism in Moroccan population: allele frequencies and relation to plasma lipid concentrations Ann Biol Clin 60 1 73 80
26. Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T (2005) Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett: 1-6
27. N Valveny EM Esteban MI Kandi P Moral 1997 ApoE polymorphism in Spanish and Moroccan populations Clin Genet 51 354 356 10.1111/j.1399-0004.1997.tb02488. x 9212187 1:STN:280:DyaK2szlsFOjtA%3D%3D